Genetics in the ADHD Clinic: How Can Genetic Testing Support the Current Clinical Practice?

• Published in: Frontiers in psychology Vol. 13; p. 751041
• Main Authors: Balogh, Lívia, Pulay, Attila J, Réthelyi, János M
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 08-03-2022
• Subjects: attention deficit hyperactivity disorder (ADHD); comorbidity; endophenotype; genetics; neurodevelopment; polygenic risk score (PRS); Psychology; comorbidity; genetics; neurodevelopment; polygenic risk score (PRS); endophenotype; psychiatry; attention deficit hyperactivity disorder (ADHD)
• ISSN: 1664-1078; 1664-1078
• DOI: 10.3389/fpsyg.2022.751041

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with a childhood prevalence of 5%. In about two-thirds of the cases, ADHD symptoms persist into adulthood and often cause significant functional impairment. Based on the results of family and twin studies, the estimated heritability of ADHD approximates 80%, suggests a significant genetic component in the etiological background of the disorder; however, the potential genetic effects on disease risk, symptom severity, and persistence are unclear. This article provides a brief review of the genome-wide and candidate gene association studies with a focus on the clinical aspects, summarizing findings of ADHD disease risk, ADHD core symptoms as dimensional traits, and other traits frequently associated with ADHD, which may contribute to the susceptibility to other comorbid psychiatric disorders. Furthermore, neuropsychological impairment and measures from neuroimaging and electrophysiological paradigms, emerging as potential biomarkers, also provide a prominent target for molecular genetic studies, since they lie in the pathway from genes to behavior; therefore, they can contribute to the understanding of the underlying neurobiological mechanisms and the interindividual heterogeneity of clinical symptoms. Beyond the aforementioned aspects, throughout the review, we also give a brief summary of the genetic results, including polygenic risk scores that can potentially predict individual response to different treatment options and may offer a possibility for personalized treatment for the therapy of ADHD in the future.